In other countries
The same active substances on other registers, the same brand first.
- ArexvyEuropean Union · GlaxoSmithKline Biologicals S.A.Same brand
- Arexvy, cjepivo protiv respiratornog sincicijskog virusa (RSV) (rekombinantno, adjuvantirano)CroatiaSame brand
- ArexvyItaly · Polvere e sospensione per sospensione iniettabile · Glaxosmithkline Biologicals S.A.Same brand
- Arexvy, poeder en suspensie voor suspensie voor injectieNetherlands · Poeder en suspensie voor suspensie voor injectie · GlaxoSmithKline Biologicals S.A.Same brand
- AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mLSingapore · 120mcg/0.5mL · injection, powder, lyophilized, for liposomal suspension · Glaxosmithkline Pte LTDSame brand
- AbrysvoEuropean Union · Pfizer Europe MA EEIGSame substance
- mResviaEuropean Union · Moderna Biotech Spain, S.L.Same substance
- AbrysvoItaly · Polvere e solvente per soluzione iniettabile · Pfizer Europe Ma EeigSame substance
- MresviaItaly · Dispersione per preparazione iniettabile · Moderna Biotech Spain, S.L.Same substance
- mRESVIA dispersie voor injectie in een voorgevulde spuit mRNA-vaccin tegen het respiratoir syncytieel virusNetherlands · Dispersie voor injectie · Moderna Biotech Spain S.L.Same substance
- mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5mlSingapore · 0.050mg/0.5ml dose · injection, solution · Moderna Biotech Singapore Pte. LTD.Same substance
- AbrysvoUnited States · 120UG · Injection · Pfizer Inc.Same substance
- mresviaUnited States · 50UG/.5ML · For Injection · ModernaTX, Inc.Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Respiratory syncytial virus vaccines
- Strength
- 120 MCG / 0.5 ML
- Dosage form
- Powder For Suspension
- Route
- Intramuscular
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 6 Sept 2023
- Registration
- DIN 02540207
- Marketing authorisation holder
- Glaxosmithkline INC
- ATC code
- J07BX05
- Supply
- SCHEDULE D